Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides

Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L. Myskowski; Alison Moskowitz; Steven M. Horwitz

doi:10.1007/s11899-016-0322-5

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides

Meenal Kheterpal, Neha Mehta-Shah, Pooja Virmani, Patricia L. Myskowski, Alison Moskowitz, Steven M. Horwitz

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.

Original language	English
Pages (from-to)	224-233
Number of pages	10
Journal	Current Hematologic Malignancy Reports
Volume	11
Issue number	3
DOIs	https://doi.org/10.1007/s11899-016-0322-5
State	Published - Jun 1 2016

Keywords

Cutaneous T-cell lymphoma
Multidisciplinary approach
Non-mycosis fungoides
Primary cutaneous B-cell lymphoma
Skin-directed treatment
Systemic treatment

Access to Document

10.1007/s11899-016-0322-5

Cite this

@article{35fb7787e7dd49379936f756920ba5fc,

title = "Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides",

abstract = "Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.",

keywords = "Cutaneous T-cell lymphoma, Multidisciplinary approach, Non-mycosis fungoides, Primary cutaneous B-cell lymphoma, Skin-directed treatment, Systemic treatment",

author = "Meenal Kheterpal and Neha Mehta-Shah and Pooja Virmani and Myskowski, {Patricia L.} and Alison Moskowitz and Horwitz, {Steven M.}",

note = "Funding Information: This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. Publisher Copyright: {\textcopyright} 2016, Springer Science+Business Media New York.",

year = "2016",

month = jun,

day = "1",

doi = "10.1007/s11899-016-0322-5",

language = "English",

volume = "11",

pages = "224--233",

journal = "Current Hematologic Malignancy Reports",

issn = "1558-8211",

number = "3",

}

TY - JOUR

T1 - Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides

AU - Kheterpal, Meenal

AU - Mehta-Shah, Neha

AU - Virmani, Pooja

AU - Myskowski, Patricia L.

AU - Moskowitz, Alison

AU - Horwitz, Steven M.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.

AB - Cutaneous lymphomas (CL) are a heterogeneous group of neoplasms characterized with clinical and histopathological variation, as well as overlap with benign dermatoses. Diagnosis and treatment of CLs is challenging and often requires a multidisciplinary approach. However, prognostic knowledge of these conditions and awareness of treatment options can help optimize appropriate use of available regimens, thereby improving care for patients. Here, we review the most recent literature and outline treatment themes for managing patients with cutaneous B-cell and T-cell lymphomas other than mycosis fungoides.

KW - Cutaneous T-cell lymphoma

KW - Multidisciplinary approach

KW - Non-mycosis fungoides

KW - Primary cutaneous B-cell lymphoma

KW - Skin-directed treatment

KW - Systemic treatment

UR - http://www.scopus.com/inward/record.url?scp=84964374541&partnerID=8YFLogxK

U2 - 10.1007/s11899-016-0322-5

DO - 10.1007/s11899-016-0322-5

M3 - Review article

C2 - 27101016

AN - SCOPUS:84964374541

SN - 1558-8211

VL - 11

SP - 224

EP - 233

JO - Current Hematologic Malignancy Reports

JF - Current Hematologic Malignancy Reports

IS - 3

ER -

Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this